Vazhaikkurichi Rajendran
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Aldosterone Activation of Trans-epithelial Iron Absorption in Human Colon
Open Date: 2018-09-01
Close Date: 2021-04-30
Grant: Close
Role of BK Channels in K+-driven Colonic Water Secretion in Health and Disease
Open Date: 2015-09-23
Close Date: 2021-08-31
Grant: Close
Role of IK channels in rat distal colon
Open Date: 1976-06-01
Close Date: 2013-08-31
Articles (8)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
The global prevalence of ulcerative colitis (UC) and Crohn’s disease (CD) is increasing, placing greater burdens on national health systems. The pathophysiology of diarrhea, the commonest debilitating symptom in patients with UC and CD, has been studied more extensively in UC, where it reflects defective colonic Na + absorption combined with changes in colonic Cl − and K + transport, which significantly reduce colonic water absorption. Dysfunctional ion transport in patients with UC is accompanied by abnormalities in tight junctional protein distribution and function, which cause the inflamed colonic epithelium to become “leakier.” Progress in understanding how abnormal colonic ion transport in UC might be influenced pharmacologically has been hampered by the low availability of clinical material. To counter this, various animal models of acute colitis have been developed, but differ in the way mucosal inflammation is induced. Identifying models that closely mimic human UC in terms of pathology and ion transport abnormalities remains challenging. However, the introduction of human colonic epithelial organoids (colonoids) has added a new and exciting dimension to research in this area. Here, we review current knowledge about abnormal colonic ion transport and barrier function in experimental and human colitis as well as the use and potential of human colonoids to better understand the pathophysiology of UC, which may ultimately lead to novel approaches to the treatment of diarrhea in this disease.
Year:
2025
Somatostatin (SOM, 2 µM) and octreotide (OCT, 0.2 µM, a long-acting synthetic analog of SOM) were equally effective in preventing chemical hypoxia-induced increases in paracellular shunt permeability/conductance in isolated human colon. In rat distal colon, chemical hypoxia significantly increased total epithelial conductance and transepithelial movement of FITC-dextran 4000, changes completely prevented by 0.2 µM OCT. OCT may prevent or limit gut ischemia during abdominal surgery, thereby decreasing the risk of bacterial/bacterial toxin translocation and sepsis.
Year:
2024
Year:
2023
Year:
2023
Collaborators (3)
Joshua Cornman-Homonoff
Assistant Professor
Yale New Haven Hospital
Karthikeyan Narayanan
Director, Stem Cell Core
Rensselaer Polytechnic Institute
Roberta Leonardi
West Virginia University
Make your next move.
Prepare your application
Review drafts before you send them.